In recent years, TFAP2A has been proved to promote the proliferation and metastasis of lung adenocarcinoma, cervical cancer, and other cancer cells, mainly by affecting EMT to promote tumor metastasis [30, 31]. Here, TFAP2A is linked to lung adenocarcinoma.